BMJ  2005;331:1081 (5 November), doi:10.1136/bmj.331.7524.1081-a

Letter

Details of HPV immunisation need not delay decision

The first 150 words of the full text of this article appear below.

EDITOR—Lowndes and Gill are upbeat in their appraisal of the future for primary prevention of cervical cancer by immunisation.1 But they then deliver a long list of questions that they suggest should be answered before starting human papillomavirus (HPV) vaccination. For most of their questions, this timing is not supported by recent historical precedent.

Without doubt ascertainment of the HPV types currently causing cancer, data for which are available in the United Kingdom,2 is central to the modelling and cost effectiveness studies with which we must assume the Health Protection Agency and others in the UK are already engaged. Certainly, as for all recent new vaccines, cost is likely to be a key determinant. Likewise, careful evaluation of vaccine acceptability to children and parents will be important, although it should be pointed out that universal immunisation against hepatitis B, primarily a sexually transmitted disease and a cancer causing . . . [Full text of this article]

Adam Finn, David Baum professor of paediatrics

Institute of Child Life and Health, Department of Clinical Sciences at South Bristol, University of Bristol, Bristol BS2 8AE Adam.Finn@bristol.ac.uk


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Articles

Data are still needed for HPV immunisation programme
O Noel Gill and Catherine M Lowndes
BMJ 2005 331: 1204. [Extract] [Full Text]

Cervical cancer, human papillomavirus, and vaccination
Catherine M Lowndes and O Noel Gill
BMJ 2005 331: 915-916. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

  • Lipke, M. M. (2006). An Armamentarium of Wart Treatments. Clin Med Res 4: 273-293 [Abstract] [Full text]  
  • Gill, O N., Lowndes, C. M (2005). Data are still needed for HPV immunisation programme. BMJ 331: 1204-1204 [Full text]  

Rapid Responses:

Read all Rapid Responses

Cervical cancer, human papillomavirus and vaccination
O Noel Gill, et al.
bmj.com, 9 Nov 2005 [Full text]
Some important questions for a programme for HPV vaccination
Catherine M Lowndes, et al.
bmj.com, 16 Dec 2005 [Full text]



Access jobs at BMJ Careers
Whats new online at Student 

BMJ